Search details
1.
BRAF-Mutated Melanoma Journey in Latin America: Expert Recommendations From Diagnosis to Treatment.
Cancer Control
; 31: 10732748241251572, 2024.
Article
in English
| MEDLINE | ID: mdl-38751033
2.
Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic.
Oncologist
; 25(10): e1562-e1573, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32888360
3.
Assessment of early response to imatinib 800 mg after 400 mg progression by ¹8F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors.
Future Oncol
; 11(6): 953-64, 2015.
Article
in English
| MEDLINE | ID: mdl-25760976
4.
The role of modern parameters and their relationship with recurrence risk as assessed by Oncotype DX: real-world evidence.
Ecancermedicalscience
; 18: 1664, 2024.
Article
in English
| MEDLINE | ID: mdl-38439804
5.
The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative Review.
Cancers (Basel)
; 16(2)2024 Jan 17.
Article
in English
| MEDLINE | ID: mdl-38254885
6.
Challenges and opportunities for sarcoma care and research in Latin America: a position paper from the LACOG sarcoma group.
Lancet Reg Health Am
; 30: 100671, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38259252
7.
Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report.
JTO Clin Res Rep
; 4(2): 100456, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36798785
8.
Short-course radiotherapy for rectal cancer: real-world evidence in Argentina.
Ecancermedicalscience
; 17: 1555, 2023.
Article
in English
| MEDLINE | ID: mdl-37396101
9.
Generalized Lymphatic Anomaly as a Differential Diagnosis of Lytic Lesions.
Case Rep Oncol
; 16(1): 597-603, 2023.
Article
in English
| MEDLINE | ID: mdl-37900803
10.
Breaking the unvirtuous cycle: barriers and opportunities for research and development in Paraguay. A case study.
Front Med (Lausanne)
; 10: 1266246, 2023.
Article
in English
| MEDLINE | ID: mdl-38034550
11.
Atypical pattern of response in rectal cancer after neoadjuvant pembrolizumab treatment: a case report, literature review, and proposed management model.
J Gastrointest Oncol
; 14(3): 1635-1642, 2023 Jun 30.
Article
in English
| MEDLINE | ID: mdl-37435212
12.
Systemic Therapy for Melanoma: ASCO Guideline Update.
J Clin Oncol
; 41(30): 4794-4820, 2023 10 20.
Article
in English
| MEDLINE | ID: mdl-37579248
13.
Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials: A systematic review.
Crit Rev Oncol Hematol
; 176: 103747, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35717006
14.
Experience of bipolar androgen therapy (BAT) in Argentinian oncology centres.
Ecancermedicalscience
; 16: 1480, 2022.
Article
in English
| MEDLINE | ID: mdl-36819799
15.
Desmoid tumour in an inguinal hernia in a patient with a previous diagnosis of melanoma.
Ecancermedicalscience
; 16: 1394, 2022.
Article
in English
| MEDLINE | ID: mdl-35919234
16.
Precision medicine in the real-world setting. Clinical activity of talazoparib in a woman with hormone receptor-positive HER2-negative metastatic breast cancer with pathogenic mutation in somatic BRCA2.
Ecancermedicalscience
; 16: 1448, 2022.
Article
in English
| MEDLINE | ID: mdl-36405946
17.
First-line cisplatin, docetaxel, and cetuximab for patients with recurrent or metastatic head and neck cancer: A multicenter cohort study.
World J Clin Oncol
; 13(2): 147-158, 2022 Feb 24.
Article
in English
| MEDLINE | ID: mdl-35316930
18.
Cyclin-Dependent Kinase 4/6 Inhibitor Outcomes in Patients With Advanced Breast Cancer Carrying Germline Pathogenic Variants in DNA Repair-Related Genes.
JCO Precis Oncol
; 6: e2100140, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35235412
19.
Implementation of a virtual multicenter gastrointestinal tumor board to reduce cancer disparities in Argentina.
World J Clin Oncol
; 13(6): 423-428, 2022 Jun 24.
Article
in English
| MEDLINE | ID: mdl-35949433
20.
Analysis of adverse events attribution and reporting in cancer clinical trials: A systematic review.
Crit Rev Oncol Hematol
; 160: 103296, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33675904